In a major policy reversal, the DoJ filed an amicus brief late yesterday saying human DNA and other genes shouldn't be eligible for patents. It's unclear whether the Patent Office will adopt the position, which could potentially force some biotech firms to change the way they develop drugs.
In a major policy reversal, the DoJ filed an amicus brief late yesterday saying human DNA and...
From other sites
Video at CNBC.com (Thu, 5:35PM)
Video at CNBC.com (Tue, 6:49AM)
Video at CNBC.com (Feb 4, 2016)
Video at CNBC.com (Feb 2, 2016)
Video at CNBC.com (Dec 3, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs